Question? Call us
212-363-7500Expired
Lead Plaintiff Deadline
Nov 20, 2018
Choose your preferred way to stay informed of new case launches and settlement deadlines
(1) AbbVie’s strategy to increase the sales growth of its blockbuster drug, HUMIRA, relied in part upon illegal kickbacks and unlawful sales and marketing tactics; (2) such practices would foreseeably lead to heightened scrutiny by State governments and agencies; and (3) as a result, Defendants’ public statements were materially false and misleading at all relevant times.
In order to be eligible to join the ABBV class action lawsuit, you must have incurred a loss on shares of purchased during the class period listed above.
If you suffered a loss in during the relevant time frame or pursuant to the relevant offering(s), you have until November 20, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
TOP